BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 14, 2015
View Archived Issues
Polyphor to use eFlow nebulizer to deliver POL-6014 for rare lung diseases
Read More
Novartis begins phase I/II study of FGF-401 in adults with solid malignancies
Read More
Enrollment open in phase II trial of OTL-38 imaging agent for ovarian cancer
Read More
Isis and Alnylam extend 2004 strategic partnership on RNA therapeutics
Read More
Incyte and Agenus to develop novel immune-oncology antibodies
Read More
Sage Therapeutics updates data on SAGE-547 for super-refractory status epilepticus
Read More
Arena initiates phase II trial of ralinepag for pulmonary arterial hypertension
Read More
Debiopharm regains rights to alisporivir from Novartis
Read More
New vasopressin V1A receptor antagonist found to influence social cognition
Read More
BioMarin reports interim data from phase I/II study of BMN-190 for CLN2 disease
Read More
Bench-side progress towards novel therapies for myeloid tumors
Read More
WuXi PharmaTech acquires NextCODE Health
Read More
Roche obtains rights to Meiji's beta-lactamase inhibitor OP-0595
Read More
Alere completes sale of healthcare services division to Optum
Read More
X-Chem and Janssen Biotech form anti-inflammatory drug discovery collaboration
Read More
Scynexis' SCY-078 receives FDA fast track designation for oral treatment of fungal infections
Read More
Arylquin-1, a Par-4 secretatogue with a novel mechanism of action
Read More
Yakult Honsha patent details novel platinum complex for cancer
Read More
Merck & Co. reports development of compounds for HCV infections
Read More
Asana BioSciences researchers prepare immunofusion molecules for cancer
Read More
Boehringer Ingelheim patent divulges novel AMPK activators
Read More
AB Science patents new SCFR inhibitors
Read More
Auspex to obtain remaining rights to SD-1077 through acquisition of Imphar
Read More
Zydus begins phase III study of saroglitazar in NASH
Read More
EMA grants positive opinion for orphan drug status for enadenotucirev
Read More
Lung Therapeutics' LTI-01 granted orphan drug designation in the E.U.
Read More
Novel biomarker associated with MDD
Read More
AbbVie and Neurocrine's elagolix reduces endometriosis pain in phase III trial
Read More